Literature DB >> 20210867

Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain.

Ian R Carroll1, Jared W Younger, Sean C Mackey.   

Abstract

OBJECTIVE: Oral sodium channel blockers have shown mixed results in randomized controlled trials despite the known importance of sodium channels in generating pain. We hypothesized that differing baseline pain qualities (e.g. "stabbing" vs "dull") might define specific subgroups responsive to intravenous (IV) lidocaine-a potent sodium channel blocker.
DESIGN: A prospective cohort study of 71 patient with chronic pain suspected of being neuropathic were recruited between January 2003 and July 2007 and underwent lidocaine infusions at Stanford University Hospital in a single-blind nonrandomized fashion. Baseline sensory pain qualities were measured with the Short-Form McGill Pain Questionnaire (SF-MPQ). Pain intensity was measured with a visual analog scale (VAS).
RESULTS: Factor analysis demonstrated two underlying pain quality factors among SF-MPQ sensory items: a heavy pain and a stabbing pain. Baseline heavy pain quality, but not stabbing quality predicted subsequent relief of pain intensity in response to lidocaine. In contrast, these factors did not predict divergent analgesic responses to placebo infusions. In response to each 1 mcg/mL increase in lidocaine plasma level, patients with high heavy pain quality drop their VAS 0.24 (95% CI 0.05-0.43) more points than those with low heavy pain quality (P < 0.013).
CONCLUSIONS: "Heavy" pain quality may indentify patients with enhanced lidocaine responsiveness. Pain quality may identify subgroups among patients with suspected neuropathic pain responsive to IV lidocaine. Further investigation is warranted to validate and extend these findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210867      PMCID: PMC2913605          DOI: 10.1111/j.1526-4637.2010.00807.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  7 in total

Review 1.  Using pain quality assessment measures for selecting analgesic agents.

Authors:  Mark P Jensen
Journal:  Clin J Pain       Date:  2006-01       Impact factor: 3.442

2.  Are sodium channel blockers useless in peripheral neuropathic pain?

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  2006-10-18       Impact factor: 6.961

3.  The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

Authors:  M Bennett
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

4.  Derivation and cross-validation of pharmacokinetic parameters for computer-controlled infusion of lidocaine in pain therapy.

Authors:  T W Schnider; R Gaeta; W Brose; C F Minto; K M Gregg; S L Shafer
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

Review 5.  Mechanisms of neuropathic pain and their implications for the design of clinical trials.

Authors:  Michael C Rowbotham
Journal:  Neurology       Date:  2005-12-29       Impact factor: 9.910

Review 6.  Systemic lidocaine for neuropathic pain relief.

Authors:  Jianren Mao; Lucy L Chen
Journal:  Pain       Date:  2000-07       Impact factor: 6.961

7.  The short-form McGill Pain Questionnaire.

Authors:  Ronald Melzack
Journal:  Pain       Date:  1987-08       Impact factor: 6.961

  7 in total
  7 in total

1.  Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms.

Authors:  Jerry P Kalangara; Anat Galor; Roy C Levitt; Derek B Covington; Katherine T McManus; Constantine D Sarantopoulos; Elizabeth R Felix
Journal:  Eye Contact Lens       Date:  2017-05       Impact factor: 2.018

2.  Sensory pain qualities in neuropathic pain.

Authors:  Sean Mackey; Ian Carroll; Birol Emir; T Kevin Murphy; Ed Whalen; Levent Dumenci
Journal:  J Pain       Date:  2011-12-15       Impact factor: 5.820

Review 3.  Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Robert R Edwards; Robert H Dworkin; Dennis C Turk; Martin S Angst; Raymond Dionne; Roy Freeman; Per Hansson; Simon Haroutounian; Lars Arendt-Nielsen; Nadine Attal; Ralf Baron; Joanna Brell; Shay Bujanover; Laurie B Burke; Daniel Carr; Amy S Chappell; Penney Cowan; Mila Etropolski; Roger B Fillingim; Jennifer S Gewandter; Nathaniel P Katz; Ernest A Kopecky; John D Markman; George Nomikos; Linda Porter; Bob A Rappaport; Andrew S C Rice; Joseph M Scavone; Joachim Scholz; Lee S Simon; Shannon M Smith; Jeffrey Tobias; Tina Tockarshewsky; Christine Veasley; Mark Versavel; Ajay D Wasan; Warren Wen; David Yarnitsky
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

4.  Effect of intravenous lidocaine on the neuropathic pain of failed back surgery syndrome.

Authors:  Chan Hong Park; Sug Hyun Jung; Chang Gyu Han
Journal:  Korean J Pain       Date:  2012-04-04

5.  The effect of topical local anesthetics on thermal pain sensitivity in patients with irritable bowel syndrome.

Authors:  Anthony Rodrigues; Christopher D King; Fong Wong; Joseph L Riley; Siegfried Schmidt; Andre P Mauderli
Journal:  Pain Res Treat       Date:  2012-02-28

Review 6.  The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review.

Authors:  Fardin Yousefshahi; Oana Predescu; Juan Francisco Asenjo
Journal:  Anesth Pain Med       Date:  2017-04-22

7.  Intra-Venous Lidocaine to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis.

Authors:  Bo Zhu; Xiayun Zhou; Qinghe Zhou; Haiyan Wang; Shougen Wang; Kaitao Luo
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.